Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence

from CHI Podcasts · host Cambridge Healthtech Podcasts

Dr. James Trager shares a preview of his talk at the NK cell-based cancer immunotherapy meeting in Boston, discusses his next step in research and the vision of Nkarta in NK cell therapy development and what he’s looking forward to at this meeting such as the topics of inhibition of MIC protein shedding and NK cell metabolism. For more information, please visit http://www.DiscoveryOnTarget.com/NK-Cell-Based-Cancer-Immunotherapy/

Episode metadata supplied by the publisher feed · Published Aug 16, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence

0:00 8:03

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CHI Podcasts?

This episode is 8 minutes long.

When was this CHI Podcasts episode published?

This episode was published on August 16, 2018.

Can I download this CHI Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!